OpenAI launches Lockdown Mode and Elevated Risk warnings to protect ChatGPT against prompt-injection attacks and reduce data-exfiltration risks.

The best defense against prompt injection and other AI attacks is to do some basic engineering, test more, and not rely on AI to protect you. If you want to know what is actually happening in ...

Computational and Communication Science and Engineering (CoCSE), The Nelson Mandela African Institution of Science and Technology (NM-AIST), Arusha, Tanzania In the face of increasing cyberattacks, ...

SAP has released its November security updates that address multiple security vulnerabilities, including a maximum severity flaw in the non-GUI variant of the SQL Anywhere Monitor and a critical code ...

NASHVILLE, Tenn. (WSMV) - A group of news organizations is suing Tennessee’s Department of Corrections commissioner and a prison warden over the limitations the state’s execution methods present to ...

You can create a release to package software, along with release notes and links to binary files, for other people to use. Learn more about releases in our docs.

The European Commission has granted marketing authorization for Gilead Sciences' twice-yearly injection for preventing HIV infection, the company said on Tuesday. Story by Eliza Herbert. Largest Home ...

Lenacapavir approved for PrEP in EU, Norway, Iceland, Liechtenstein Pricing, reimbursement to be determined with each country Gilead's lenacapavir nearly 100% effective in trials Aug 26 (Reuters) - ...

Automakers have long touted the benefits of fuel injection, claiming increased efficiency and power. But as more cars have the system installed (around 73% in 2023), more and more consumers are ...

Share on Pinterest Lenacapavir is a twice-yearly injection to prevent HIV that could improve adherence rates compared to other PrEP medications. d3sign/Getty Images The WHO issued a global ...

The US Food and Drug Administration on Wednesday approved Gilead Sciences' twice-yearly injection to prevent HIV, a move the company hailed as a major breakthrough in the fight against the sexually ...

The US Food and Drug Administration on Wednesday approved Gilead Sciences' twice-yearly injection to prevent HIV -- a move the company hailed as a major breakthrough in the fight against the sexually ...